News for 'National Institute of Health'

G20 Summit: Dream Come True For India

G20 Summit: Dream Come True For India

Rediff.com11 Sep 2023

India's dream to be in the forefront of international politics has come true. India has placed itself firmly as a major player in the shaping of a new world order, observes Ambassador T P Sreenivasan.

Full Text: PM Modi's address to US Congress

Full Text: PM Modi's address to US Congress

Rediff.com23 Jun 2023

Here's the full text of Prime Minister Narendra Modi's address to a joint session of the United States Congress, delivered on Thursday.

To condemn every man as rapist is not advisable: Irani on marital rape issue

To condemn every man as rapist is not advisable: Irani on marital rape issue

Rediff.com2 Feb 2022

The government's endeavour, she said, is to protect women in this country in collaboration with state governments.

'India needs insurers catering to niche sectors like NBFCs, MFIs'

'India needs insurers catering to niche sectors like NBFCs, MFIs'

Rediff.com23 Dec 2022

India has a huge untapped population which doesn't have facilities for financial aid and insurance, and it is perhaps plausible to look at the option of having niche players catering to smaller sectors akin to non-banks and microfinance institutions in lending, said Rakesh Joshi, member (Finance & Investment), Insurance Regulatory and Development Authority of India (Irdai). Speaking at the Business Standard BFSI Insight Summit, Joshi said, "Today, most of our insurance companies operate at a national level. There is arguably a case for having differentiated operations, which cater to niche sectors the same way we have non-banking financial companies (NBFC) and microfinance institutions in lending." "The capital requirement for niche players may not be as large as those having national ambitions. "Enabling these niche players, which require lower capital, will enhance the penetration in areas which hitherto had not seen traction from large players," he said.

China denies coronavirus leaked from Wuhan lab, says global outbreaks caused pandemic

China denies coronavirus leaked from Wuhan lab, says global outbreaks caused pandemic

Rediff.com4 Jan 2021

"We raced against time and were the first country to report cases to the world," Chinese foreign minister Wang Yi said in interviews to the official media over the weekend.

Modi meets 7 Covid vaccine manufacturers

Modi meets 7 Covid vaccine manufacturers

Rediff.com23 Oct 2021

The prime minister was happy that the assurance given by the Serum Institute that it will make India self-sufficient in vaccines at the lowest possible price in the world was fulfilled.

Was absolutely not surprised Trump got Covid: Fauci

Was absolutely not surprised Trump got Covid: Fauci

Rediff.com19 Oct 2020

During the interview with the CBS, Fauci said it does not make sense to him why Trump "equates wearing a mask with weakness." Masks, Fauci maintained, "really do work."

Oxford launches COVID-19 vaccine study on children

Oxford launches COVID-19 vaccine study on children

Rediff.com13 Feb 2021

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.

What the Modi Sarkar needs to do for Indians' health

What the Modi Sarkar needs to do for Indians' health

Rediff.com26 May 2016

'Make sure your public hospitals work.' 'Don't allow people to go shopping for expensive services; provide them yourself as the government and then charge them very little or nothing at all.'

More than skin-deep: Nifty Next 50 complexion to get a shade of difference

More than skin-deep: Nifty Next 50 complexion to get a shade of difference

Rediff.com12 Jun 2023

The National Stock Exchange (NSE) Nifty Next 50 Index could undergo large-scale changes if the proposed tweaks to its computation methodology get implemented. In a discussion paper floated recently, NSE Indices, which owns and manages a portfolio of over 350 indices under the Nifty brand, proposed that only stocks that are traded in the futures and options (F&O) segment can be part of the index. Currently, as many as 11 non-F&O stocks are part of the Nifty Next 50 Index, which, as the name suggests, represents the next rung of large and liquid securities after the Nifty50.

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Most narcotics are shipped in Pakistan, Amit Shah tells conference

Most narcotics are shipped in Pakistan, Amit Shah tells conference

Rediff.com24 Mar 2023

Union Home Minister Amit Shah said on Friday security in the ocean needs to be strengthened as most of the narcotic drugs are shipped in Pakistan and go via Iran to Sri Lanka and Africa.

India reports first case of Coronavirus; Kerala woman tests positive

India reports first case of Coronavirus; Kerala woman tests positive

Rediff.com31 Jan 2020

The government will also evacuate Indians on Friday from China's Wuhan city, the epicentre of the deadly Coronavirus, which has spread to at least 17 countries already.

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

'I Had 10 Ideas When I Quit My Job'

'I Had 10 Ideas When I Quit My Job'

Rediff.com19 Dec 2023

'When I was toying with 10 different ideas, my father was diagnosed with lung fibrosis and his condition deteriorated so badly that we lost him in six months. He was very unsatisfied with the lack of proper diagnosis.' 'It made me think will anyone do a biopsy if there is no symptom? Why is it that we do not have any non-invasive diagnostic method?' 'This idea was the strongest out of the ten, and with Snahlata Singh with her cancer biology background joining me, the idea got a real boost.'

Centre rushes team to Kerala after Nipah confirmation

Centre rushes team to Kerala after Nipah confirmation

Rediff.com4 Jun 2019

A control room has also been set up and the Strategic Health Operations Centre (SHOC) of the National Centre for Disease Control (NCDC) has been activated, phone number for which is 011-23978046, a health ministry statement stated.

British Indian doc's call for Delhi to suspend Covishield use finds support

British Indian doc's call for Delhi to suspend Covishield use finds support

Rediff.com6 Feb 2023

A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.

New Covid strain: Andhra woman escapes detection at Delhi airport

New Covid strain: Andhra woman escapes detection at Delhi airport

Rediff.com24 Dec 2020

A coronavirus positive woman allegedly managed to give the slip to authorities in New Delhi after her arrival from London and reached Andhra Pradesh by train only to be picked up by authorities and admitted to a hospital.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Experts downplay apprehensions centred around Covid XE

Experts downplay apprehensions centred around Covid XE

Rediff.com7 Apr 2022

Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.

Delhi declares black fungus as epidemic, number of cases rises

Delhi declares black fungus as epidemic, number of cases rises

Rediff.com27 May 2021

Amid rising incidents of black fungus in the national capital, the Delhi government on Thursday declared it an epidemic with Lt Governor Anil Baijal issuing regulations under the Epidemic Diseases Act to contain and manage cases of the deadly mucormycosis in the city.

Sorry state of affairs: SC on lack of sexual harassment panels at workplace

Sorry state of affairs: SC on lack of sexual harassment panels at workplace

Rediff.com12 May 2023

The top court said there are serious lapses in the enforcement of the 2013 Prevention of Sexual Harassment Act.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

'I learned how people in India persevere'

'I learned how people in India persevere'

Rediff.com18 Feb 2011

As part of an ongoing series, we bring you stories of young Indian Americans who came looking for the Real India and found their real selves instead. Nilay Suresh Shah recounts his trip to India.

Kerala lifts coronavirus 'state calamity' alert

Kerala lifts coronavirus 'state calamity' alert

Rediff.com7 Feb 2020

But that does not mean that we are lowering our guard. The (28-day) quarantine period will continue.

Find solution to save career of foreign-returned students: SC to govt, NMC

Find solution to save career of foreign-returned students: SC to govt, NMC

Rediff.com9 Dec 2022

The top court said it hoped the Centre will give due importance to its suggestion and find out a solution to save the career of the students who are an asset of the country.

India's Omicron tally near 1,200, Maha cases at 450, community spread in Delhi

India's Omicron tally near 1,200, Maha cases at 450, community spread in Delhi

Rediff.com30 Dec 2021

According to the latest data available from the Centre and the states in the night, the total number of Omicron cases in the country was around 1,200.

Coronavirus: 99 more who returned from China are under observation

Coronavirus: 99 more who returned from China are under observation

Rediff.com26 Jan 2020

Samples of these seven passengers have been sent to the ICMR-NIV Pune lab. Samples of four other passengers tested earlier have been confirmed to be negative for nCoV by the lab.

Omicron scare: SII seeks approval for Covishield booster

Omicron scare: SII seeks approval for Covishield booster

Rediff.com2 Dec 2021

The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.

US trade body hails Budget, says it's fiscally prudent

US trade body hails Budget, says it's fiscally prudent

Rediff.com2 Feb 2022

In the midst of third wave of COVID-19, Finance Minister Nirmala Sitharaman has come up with an impactful Budget which is balanced, fiscally prudent and growth-oriented, the USA India Chamber of Commerce has said. President of the Boston-based USA India Chamber of Commerce (USAIC) Karun Rishi, however, said it is a matter of concern that the budget lacks tangible measures to increase revenue generation. "Opting to keep the fiscal deficit at 6.9 per cent and increase capital expenditure by 35 per cent is a masterstroke. "The annual budget estimates the effective capital expenditure of Rs 10.68 lakh crore in 2022-23, making up about 4.1 per cent of the GDP," he said. "A phenomenal increase in the government's capital expenditure is likely to facilitate the expenditures on infrastructure and create jobs.

Trump unveils 3-phase plan to reopen country

Trump unveils 3-phase plan to reopen country

Rediff.com17 Apr 2020

Currently more than 95 per cent of America's 330 million population are under a stay-at-home order and over 22 million Americans have applied for unemployment benefits.

Coronavirus: Kerala student 'stable'; 3 held for spreading rumours

Coronavirus: Kerala student 'stable'; 3 held for spreading rumours

Rediff.com1 Feb 2020

The woman, who tested positive, is a student of Wuhan university and is undergoing treatment at the Thrissur Medical College Hospital. 3 people have been arrested for spreading false information about those who had arrived in the state from coronavirus affected countries.

'It is common for any virus to mutate'

'It is common for any virus to mutate'

Rediff.com22 Dec 2020

'There is no data to show this virus is more deadlier.'

Biden proposes over $25 bn spend in Indo-Pacific to out-compete China

Biden proposes over $25 bn spend in Indo-Pacific to out-compete China

Rediff.com10 Mar 2023

This includes over $15 billion of proposed investment in the infrastructure sector in the Indo-Pacific and $9 billion for shoring up American defence in the region.

Nipah virus claims 1 more life in Kerala, toll climbs to 13

Nipah virus claims 1 more life in Kerala, toll climbs to 13

Rediff.com27 May 2018

After the outbreak of Nipah at a hamlet in Perambra last week, 16 people have tested positive, of whom 13 have died so far.

India administers over 100 crore anti-Covid jabs

India administers over 100 crore anti-Covid jabs

Rediff.com21 Oct 2021

The prime minister also visited the Ram Manohar Lohia Hospital in New Delhi after the milestone was achieved and interacted with hospital officials.

SC asks Centre to make portal for Ukraine returned medical students

SC asks Centre to make portal for Ukraine returned medical students

Rediff.com16 Sep 2022

The Supreme Court on Friday suggested that the Centre assist the medical students who had returned to the country from Ukraine in view of the war with Russia by creating a web portal giving details of the foreign universities, where they could complete their courses as per the government's academic mobility programme.

Indian economy in better shape than a year ago, says economist Pinaki Chakraborty

Indian economy in better shape than a year ago, says economist Pinaki Chakraborty

Rediff.com29 Nov 2021

India's macroeconomic situation is certainly better than what it was a year ago, eminent economist Pinaki Chakraborty said on Monday, while expressing hope that the country will be back on the path of economic growth if there is no major third wave of the COVID-19 pandemic. In an interview with PTI, Chakraborty, who is the director of the National Institute of Public Finance and Policy (NIPFP), said that inflation may remain at an elevated level as there was a significant fiscal and monetary expansion in the last 18 months. "The current macroeconomic situation is certainly much better than what it was one year back. We are seeing recovery in most sectors," he said. Chakraborty noted that COVID-19 vaccination has been going on at a very fast rate in India.

Booster jab should protect current, future Covid strains: Randeep Guleria

Booster jab should protect current, future Covid strains: Randeep Guleria

Rediff.com23 Mar 2023

The renowned pulmonologist, who was part of the national COVID task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.